Can white blood cell (WBC) count increase after blood transfusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 30, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

From the Research

Yes, white blood cell count can increase after a blood transfusion, as evidenced by a study published in 2004 1, which found that transfusion of non-filtered packed red cells may frequently cause an acute and transient leukocytosis in critically ill nonseptic patients. This phenomenon occurs through several mechanisms, including the transfused blood product itself containing white blood cells, especially if it's not leukoreduced, and the recipient's body mounting an inflammatory response to the transfused blood, triggering white blood cell production. The study found that the white blood cell count in nonseptic patients increased from 14.3 +/- 4.8 before transfusion to 19.5 +/- 7.0 2 hrs following transfusion (p <.001) and returned to baseline in 24 hrs 1. Additionally, the study suggested that interleukin-8 accumulating in stored non-filtered packed red cells may play a role in this phenomenon, as the concentrations of interleukin-8 were higher in units that caused leukocytosis in the recipients compared with those that did not (408.4 +/- 202 vs. 65.1 +/- 49, p =.02) 1. It's worth noting that most modern blood products are leukoreduced to minimize these reactions, but temporary white count elevations can still occur within hours to days after transfusion, as discussed in a study published in 2016 2. However, the most recent study available, published in 2025 3, although not directly related to blood transfusions, highlights the importance of considering other factors that may cause leukocytosis, such as corticosteroid use. In the context of blood transfusions, the key takeaway is that a transient increase in white blood cell count after transfusion is a recognized phenomenon, and clinicians should be aware of this when interpreting laboratory results in patients who have received blood transfusions.

Related Questions

In an 82-year-old woman with a white blood cell count increasing from 11.6 ×10⁹/L to 13.1 ×10⁹/L and neutrophil proportion rising from 61% to 71% over 24 hours, what is the likely cause and recommended management?
In a female patient with fever, leukocytosis, elevated C‑reactive protein, basal crackles and recent chemotherapy who currently has no dyspnea, should I still administer salbutamol (albuterol) and prednisone?
In a patient who received a single 50 mg dose of prednisone and recently underwent chemotherapy, with a leukocyte count of 11.5 ×10⁹/L, elevated C‑reactive protein, and low‑grade fever (37.5‑37.7 °C), is the leukocytosis likely a prednisone side effect or indicative of an underlying inflammatory or infectious process?
Can a cortisone (corticosteroid) shot cause an elevated white blood cell count in a general adult population?
How should I manage a patient with a rapid 3‑g/dL drop in hemoglobin over two days, a white blood cell count decreasing from 19 to 15 ×10⁹/L, chronic glucocorticoid therapy, newly restarted levothyroxine (Synthroid), and a markedly elevated thyroid‑stimulating hormone of 62 mIU/L?
When should a patient be placed on neutropenic (having an abnormally low number of neutrophils, a type of white blood cell) precautions?
What is the evidence comparing intravenous (IV) steroids to oral (PO) steroids in the treatment of acute Chronic Obstructive Pulmonary Disease (COPD)?
What is the target blood glucose level in Diabetic Ketoacidosis (DKA)?
How does blood pressure change as blood moves from arteries to veins?
Can the optimization and integration of Electronic Health Records (EHRs), Clinical Decision Support Systems (CDSS), and telemedicine platforms improve patient care and clinical outcomes?
What is knife edge atrophy in Brain Magnetic Resonance Imaging (MRI)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.